Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by FarmerBetty

PMN

RE:RE:RE:RE:RE:Insider buying today :

Some more insider buying by Eugene, but this horse is going nowhere but down...

June 24, 2022

PMN

RE:RE:RE:Filing of form 10

Not languishing on the 1014 page report but it is kind interesting how they...

June 23, 2022

PMN

Filing of form 10

Really, what a stupid news release find another company that announced this...

June 22, 2022

PMN

RE:RE:RE:acu193 question

You got to love it ,remove Acumen from today's Corporate update with how...

June 21, 2022

PMN

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Strong Buy

Acumen in the Alzheimer space like Promis was $26.98 when they went on the...

June 16, 2022

PMN

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Strong Buy

No not the only argument as i have posted in the past companies like Acumen...

June 16, 2022

PMN

RE:RE:RE:RE:RE:RE:RE:RE:RE:Strong Buy

b-ball, google Freeze-out tatics the reverse stock split-schwartz? By a law...

June 16, 2022

PMN

RE:RE:RE:RE:RE:RE:RE:Strong Buy

Who said anything about a share dilution with a deal? No dilution with the...

June 16, 2022

PMN

RE:RE:RE:RE:RE:Strong Buy

Not nonsense, many billionaires put there own rules in place.  You can&...

June 16, 2022

PMN

RE:RE:RE:Strong Buy

Interesting Promis doesn't communicate that one of the Boston group is...

June 16, 2022

PMN

RE:RE:Amx0035 conditional approval in Canada

Rudy Tanzi has been on Promis for a number of years, seeing very liittle new...

June 14, 2022

PMN

RE:RE:Biogen/Alectos announce license and Collaboration agreement

Your response tells me you are either Elliott or Eugene not sure which one. I...

June 7, 2022

PMN

RE:RE:Biogen/Alectos announce license and Collaboration agreement

Yes, Management team 4, Scientific Advisory board 4, and 4 different products...

June 7, 2022

PMN

Biogen/Alectos announce license and Collaboration agreement

Parkinsons- Biogen will make an upfront payment of $15 million. Alectos to...

June 7, 2022

PMN

RE:RE:RE:RE:RE:RE:RE:The Big IF

A couple of reasons for being hesitant look at the example below which...

June 5, 2022

PMN

RE:RE:RE:The Big IF

No i mean before the start of phase 1. If they can't partner this with...

June 2, 2022

PMN

RE:The Big IF

I think it would be a strategic mistake not to partner berfore phase 1...

June 1, 2022

PMN

NexImmune

Was watching this one last year anothe Nasdaq darling on about February 2021 ...

June 1, 2022

PMN

RE:RE:RE:RE:RE:0.50 CAD by Years End

You can count on one hand the number of Boston investors that have 125/430...

May 24, 2022

PMN

RE:RE:RE:RE:RE:0.50 CAD by Years End

You can count on one hand the number of Boston investors that have 125/430...

May 24, 2022

Prev 1 2 3 4 5 6 7 8 9 10 Next

Featured Company

Tidal Care Inc.

Tidal Care Inc. P.TDL

Tidal Care aims to be a high-compliance supplier of finished, formulated Psilocybin- and MDMA-based drug products to the ... view more »